Queensland Brain Institute (QBI) researchers will propel scientific discovery into DNA mutations, treating human movement disorders and improving stroke outcomes after securing funding from the Australian Government.
Professor Steven Zuryn, Associate Professor Susannah Tye and Dr Matilde Balbi were awarded a share of over $5 million to advance projects across neuroscience and brain disease as part of the National Health and Medical Research Council (NHMRC) Ideas Grant scheme.
As part of the scheme, 190 projects across Australia will receive funding to deliver better healthcare for Australians from early discovery through to practical solutions.
NHMRC Chief Executive Officer Professor Steve Wesselingh said innovation in health and medical research was the driving force behind so many past discoveries that have helped shape Australia’s healthcare system.
“By empowering our researchers to pursue their bold ideas and collaborate with others, we strengthen the sector’s ability to tackle complex health challenges," Professor Wesselingh said.
“Congratulations to the researchers receiving funding today - supporting your research innovation ensures that our sector remains at the forefront of global progress, delivering better health outcomes for Australians.”
The QBI projects are:
Dr Matilde Balbi
Non-invasive modulation of astrocyte-mediated fluid exchange to improve stroke outcome
Associate Professor Susannah Tye
An intelligent deep brain stimulation approach for treating human movement disorders
Professor Steven Zuryn
Combatting mitochondrial DNA mutations with epigenetics
Combatting mitochondrial DNA mutations using microbe-host signalling
